169
Views
11
CrossRef citations to date
0
Altmetric
Research Article

In-vivo anti-tumor activity of a novel poloxamer-based thermosensitive in situ gel for sustained delivery of norcantharidin

, , , , , , & show all
Pages 623-629 | Received 08 Oct 2017, Accepted 18 Nov 2018, Published online: 09 Dec 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Benjian Gao, Jia Luo, Ying Liu, Song Su, Shaozhi Fu, Xiaoli Yang & Bo Li. (2021) Intratumoral Administration of Thermosensitive Hydrogel Co-Loaded with Norcantharidin Nanoparticles and Doxorubicin for the Treatment of Hepatocellular Carcinoma. International Journal of Nanomedicine 16, pages 4073-4085.
Read now
Weipeng Wei, Hongfang Li, Chengchen Yin & Fushan Tang. (2020) Research progress in the application of in situ hydrogel system in tumor treatment. Drug Delivery 27:1, pages 460-468.
Read now

Articles from other publishers (9)

Ana Camila Marques, Paulo Cardoso Costa, Sérgia Velho & Maria Helena Amaral. (2023) Injectable Poloxamer Hydrogels for Local Cancer Therapy. Gels 9:7, pages 593.
Crossref
Gabriel Martínez-Razo, Patrícia C. Pires, María Lilia Domínguez-López, Francisco Veiga, Armando Vega-López & Ana Cláudia Paiva-Santos. (2023) Norcantharidin Nanoemulsion Development, Characterization, and In Vitro Antiproliferation Effect on B16F1 Melanoma Cells. Pharmaceuticals 16:4, pages 501.
Crossref
Gabriel Martínez-Razo, María Lilia Domínguez-López, José M. de la Rosa, Diego A. Fabila-Bustos, Elba Reyes-Maldonado, Eliezer Conde-Vázquez & Armando Vega-López. (2022) Norcantharidin toxicity profile: an in vivo murine study. Naunyn-Schmiedeberg's Archives of Pharmacology 396:1, pages 99-108.
Crossref
Bing-Tao Zhai, Jing Sun, Ya-Jun Shi, Xiao-Fei Zhang, Jun-Bo Zou, Jiang-Xue Cheng, Yu Fan, Dong-Yan Guo & Huan Tian. (2022) Review targeted drug delivery systems for norcantharidin in cancer therapy. Journal of Nanobiotechnology 20:1.
Crossref
Qian Liu, Henglai Sun, Xinyu Li, Huagang Sheng & Liqiao Zhu. (2022) Strategies for Solubility and Bioavailability Enhancement and Toxicity Reduction of Norcantharidin. Molecules 27:22, pages 7740.
Crossref
Li-jun Du, Yu-xiang Feng, Zhi-xing He, Lin Huang, Qiao Wang, Cheng-ping Wen & Yun Zhang. (2021) Norcantharidin ameliorates the development of murine lupus via inhibiting the generation of IL-17 producing cells. Acta Pharmacologica Sinica 43:6, pages 1521-1533.
Crossref
Zijun Yan, Kun Yang, Xiang Tang, Yunfeng Bi, Yuzhen Ding, Mengyue Deng, Die Xia, Yunqi Zhao & Tong Chen. (2022) Norcantharidin Nanostructured Lipid Carrier (NCTD-NLC) Suppresses the Viability of Human Hepatocellular Carcinoma HepG2 Cells and Accelerates the Apoptosis. Journal of Immunology Research 2022, pages 1-10.
Crossref
Anna P Constantinou & Theoni K Georgiou. (2021) Pre‐clinical and clinical applications of thermoreversible hydrogels in biomedical engineering: a review. Polymer International 70:10, pages 1433-1448.
Crossref
Eleonora Russo & Carla Villa. (2019) Poloxamer Hydrogels for Biomedical Applications. Pharmaceutics 11:12, pages 671.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.